Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Phase 4 Study of Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Terminated
Surgical approach changed therefore subject enrollment not possible.
Other terminated trials from Hospira, now a wholly owned subsidiary of Pfizer
- Brain Ischemia · Phase PHASE2 · Dec 2021
- Chemotherapy-Induced Neutropenia · Jan 2017
- Critical Illness · Phase PHASE4 · Sep 2015
- Inflammation · Phase NA · Jan 2012
- Cancer · Phase PHASE3 · Aug 2011
See all terminations from Hospira, now a wholly owned subsidiary of Pfizer
This PHASE4 trial investigates Length of Stay and Respiration, Artificial and is currently terminated or withdrawn. Hospira, now a wholly owned subsidiary of Pfizer leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 3 earlier versions
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Feb 2017 — May 2017 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospira, now a wholly owned subsidiary of Pfizer
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .